Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Gockerman, JP; Raney, M; Logan, T

Published Date

  • September 1985

Published In

Volume / Issue

  • 69 / 9

Start / End Page

  • 1029 - 1030

PubMed ID

  • 3861247

Pubmed Central ID

  • 3861247

International Standard Serial Number (ISSN)

  • 0361-5960

Language

  • eng

Conference Location

  • United States